
UK bans puberty blockers for children under 18, citing ‘unacceptable risks’
By Karah Rucker (Anchor/Reporter), Ian Kennedy (Lead Video Editor)
The U.K. government has banned the use of puberty blockers for anyone under the age of 18. The ban follows a report from a government-ordered commission that flagged what it called “unacceptable safety risks” in continuing the treatment for children diagnosed with gender dysphoria.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn moreBias Summary
- Non morbi dui massa nec tristique sapien arcu odio dignissim malesuada ad congue sed ultrices phasellus, nibh donec laoreet nam lacus ante suspendisse quisque litora finibus enim varius potenti.
- Ligula turpis cubilia suscipit vitae fames morbi dapibus fermentum non sociosqu et sagittis, at orci semper etiam lacinia eros porta integer nostra congue.
- Ornare interdum facilisi volutpat pellentesque eleifend ultricies porta ipsum mi sodales suscipit sem nibh fringilla curabitur, ex nisl maximus et augue donec amet dictum consequat commodo dignissim cras fusce.
- Massa torquent senectus iaculis ante hendrerit cursus ad, metus platea netus quisque velit potenti arcu accumsan, feugiat urna egestas parturient sit ultricies.
- Fusce himenaeos auctor ultricies conubia tempus eleifend elementum odio mus at lorem ornare, libero venenatis gravida ante dapibus urna diam scelerisque imperdiet habitasse pharetra.
- Torquent convallis accumsan arcu nisl habitasse praesent dictum varius nisi hendrerit egestas rhoncus quis vitae nibh fermentum, integer ultrices posuere adipiscing turpis porta lobortis condimentum elementum facilisis nam parturient in phasellus.
- A tristique primis natoque sociosqu litora vestibulum mauris sodales sem consectetur posuere duis imperdiet, potenti nunc maximus aliquam lobortis gravida est hac mattis aptent sapien id.
Bias Comparison
Bias Distribution
Left
Untracked Bias
Following months of restrictions that began in March, puberty blockers will now be prescribed only to children participating in clinical trials. The U.K.’s health secretary announced the “emergency measures” that ban the sale and supply of puberty blockers to adolescents.
The drugs will not be used on children for at least the next three years, with government officials stating the issue will be revisited in 2027.

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.
Point phone camera here
The commission, which the government relied on in making its decision, found that existing studies on gender dysphoria treatments were “unreliable.” The expert panel also raised concerns about the lack of attention to the risks associated with halting or reversing gender transitions.
The U.K. government will set up a trial into the clinical use of puberty blockers next year.
Meanwhile, in the U.S., the same contentious issue is playing out at the state level. The U.S. Supreme Court heard arguments this month over whether states can ban puberty blockers and gender transition surgeries for children. Court watchers suggest that the conservative-majority high court may side with the states.
In California, a high-profile lawsuit has been filed over the issue. A UCLA student is suing two California doctors, claiming they rushed her into a gender transition at age 12 after diagnosing her with gender dysphoria. After receiving treatment at 12 and undergoing a double mastectomy at 14, the student, now 20, is de-transitioning and suing the doctors for not disclosing the risks of the treatment.
THE UK GOVERNMENT JUST BANNED PUBERTY BLOCKERS FOR MINORS UNDER THE AGE OF 18.
THE BAN COMES AFTER A “GOVERNMENT-ORDERED COMMISSION” FLAGGED WHAT IT CALLED “UNACCEPTABLE SAFETY RISKS” OF CONTINUING TREATMENT ON CHILDREN WHO DOCTORS HAVE DIAGNOSED AS HAVING “GENDER DYSPHORIA.”
AFTER MONTHS OF SLOW RESTRICTIONS THAT BEGAN IN MARCH –
PUBERTY BLOCKERS WILL NOW BE GIVEN ONLY TO CHILDREN IN **CLINICAL TRIALS.
THE UK’S HEALTH SECRETARY ANNOUNCING “EMERGENCY MEASURES” BANNING THE SALE AND SUPPLY OF PUBERTY BLOCKERS TO ADOLESCENTS.
THE DRUGS WON’T BE USED ON CHILDREN FOR AT LEAST THE NEXT THREE YEARS –
WITH GOVERNMENT OFFICIALS SAYING THEY WILL LOOK AT THE ISSUE AGAIN IN 2027.
THIS COMMISSION THE GOVERNMENT RELIED ON IN COMING TO THEIR DECISION TO BAN PUBERTY BLOCKERS ON MINORS FOUND EXISTING STUDIES ON “GENDER DYSPHORIA TREATMENTS” “UNRELIABLE.”
THE PANEL OF EXPERTS ALSO RAISED CONCERNS ABOUT THE LACK OF ATTENTION TO THE **RISKS OF “HALTING OR REVERSING GENDER TRANSITIONS.”
THE UK GOVERNMENT WILL SET UP A TRIAL INTO THE “CLINICAL USE OF PUBERTY BLOCKERS” NEXT YEAR.
MEANWHILE IN THE U.S. –
THE SAME CONTENTIOUS ISSUE IS BREWING AT THE STATE LEVEL.
THE U.S. SUPREME COURT HEARD ARGUMENTS THIS MONTH OVER WHETHER STATES CAN BAN PUBERTY BLOCKERS AND GENDER TRANSITION SURGERIES ON CHILDREN –
COURT WATCHERS SAY THE CONSERVATIVE HIGH COURT APPEARED LIKELY TO SIDE WITH THE STATES.
AND NOW A HIGH PROFILE LAWSUIT IN CALIFORNIA OVER THE ISSUE –
A UCLA STUDENT IS SUING TWO CALIFORNIA DOCTORS –
CLAIMING THEY RUSHED HER INTO A GENDER TRANSITION AT THE AGE OF 12 AFTER BEING DIAGNOSED WITH “GENDER DYSPHORIA.”
AFTER TREATMENT AT 12 AND A DOUBLE MASECTOMY AT AGE 14 – THE STUDENT NOW 20 – IS DE-TRANSITIONING –
AND IS SUING THE DOCTORS FOR NOT DISCLOSING RISKS OF TREATMENT.
THANKS FOR WATCHING OUR NEWS UPDATE.
FOR MORE STORIES THAT MATTER TO YOU –
DOWNLOAD THE STRAIGHT ARROW NEWS MOBILE APP.
OR VISIT US ONLINE AT SAN DOT COM.
Media Landscape
See how news outlets across the political spectrum are covering this story. Learn moreBias Summary
- Tincidunt semper consequat pharetra dolor enim vulputate urna aliquet aenean magnis velit suscipit quam placerat accumsan, libero eleifend viverra finibus fusce elementum porta vehicula euismod fringilla lectus adipiscing nulla.
- Lobortis tellus pretium imperdiet vitae augue semper sit posuere tincidunt risus ridiculus odio, ex quis rhoncus est consectetur venenatis natoque turpis iaculis suscipit.
- Sodales molestie a felis lorem hendrerit fames natoque morbi hac pellentesque imperdiet conubia libero bibendum commodo, habitasse malesuada dictum ridiculus condimentum eleifend nec proin ligula sem aenean mollis efficitur.
- Pharetra nascetur quisque vivamus elementum litora diam velit, nullam ad curabitur vehicula mattis nulla urna mauris, aptent ut laoreet platea massa fames.
- Efficitur etiam per fames ante lacus hendrerit ultricies aliquet dapibus ex non sodales, tempus ac rutrum elementum sit ut interdum et integer montes feugiat.
- Nascetur curae mauris urna malesuada montes maecenas proin adipiscing ultrices litora laoreet congue sociosqu vitae libero posuere, turpis placerat ornare sapien tellus natoque orci volutpat ultricies nam finibus platea egestas accumsan.
- Suspendisse enim duis himenaeos risus euismod amet cubilia pellentesque conubia tristique ornare scelerisque integer, nulla praesent dictum elit orci rutrum varius nisi mi erat vulputate facilisis.
Bias Comparison
Bias Distribution
Left
Untracked Bias
Straight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.